These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.). Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954 [TBL] [Abstract][Full Text] [Related]
27. Pulmonary toxicity by an oral anti-neoplatic agent, S-1. Ohara G; Satoh H; Hizawa N Intern Med; 2008; 47(3):187; author reply 189. PubMed ID: 18239333 [No Abstract] [Full Text] [Related]
32. Raynaud's phenomenon possibly induced by a compund drug of tegafur and uracil. Seishima M; Izumi T; Kanoh H Eur J Dermatol; 2000; 10(1):55-8. PubMed ID: 10694301 [TBL] [Abstract][Full Text] [Related]
33. [Evaluation of knuckle-pad-like changes in ceratoma palmare et plantare]. TRINKAUS T Dermatol Wochenschr; 1952; 126(37):879-83. PubMed ID: 12979631 [No Abstract] [Full Text] [Related]
34. Myotonia and keratoderma induced by 20,25 diazacholestenol. Anderson PC; Martt JM Arch Dermatol; 1965 Aug; 92(2):181-3. PubMed ID: 11850925 [TBL] [Abstract][Full Text] [Related]
35. Chronic liver failure induced by long-term administration of tegafur: a case report. Matsumoto M; Nakao K; Matsumoto H; Iwata K; Ohta Y; Kanai K; Takahashi K; Akima M Hepatogastroenterology; 1998; 45(24):2372-5. PubMed ID: 9951926 [TBL] [Abstract][Full Text] [Related]
36. [A Case of Recurrent Gallbladder Cancer with a Complete Response to S-1 Alternate-Day Administration]. Eto R; Nakatsu H; Ozasa H; Shimizu R Gan To Kagaku Ryoho; 2016 Jan; 43(1):111-3. PubMed ID: 26809537 [TBL] [Abstract][Full Text] [Related]
37. [Biochemical modulation by leucovorin of the antineoplastic effect of fluorofur in disseminated colorectal cancer]. Manziuk LV; Perevodchikova NI; Gorbunova VA; Luk'ianchenko AB; Abramova NA Vopr Onkol; 1996; 42(3):33-6. PubMed ID: 8801738 [No Abstract] [Full Text] [Related]
38. Chronic active hepatitis and liver cirrhosis in association with combined tamoxifen/tegafur adjuvant therapy. Maruyama S; Hirayama C; Abe J; Tanaka J; Matsui K Dig Dis Sci; 1995 Dec; 40(12):2602-7. PubMed ID: 8536519 [TBL] [Abstract][Full Text] [Related]
39. The Clinical Evaluation of Tegafur Gimeracil Oteracil Combined with THP and DDP for Second-Line Treatment of Advanced Cardiac Carcinoma. Wang HF; Lv JQ Cell Biochem Biophys; 2015 Jul; 72(3):695-9. PubMed ID: 25618173 [TBL] [Abstract][Full Text] [Related]